Market Snapshot

BSE Sensex: 72243.24 -0.34%
BSE 500: 31932.71 -0.51%
BSE 200: 9998.46 -0.51%
BSE 100: 22974.27 -0.43%
BSE Mid-Cap: 39783.32 -0.94%
BSE Small-Cap: 45215.78 -0.52%
BANKEX: 52946.05 -0.44%
BSE IT Sector: 33922.51 -1.20%
Nifty 50: 21916.5 -0.36%
Nifty 500: 20218.6 -0.52%
Nifty 200: 12217.9 -0.53%
Nifty 100: 22639.05 -0.44%
Nifty Midcap 100: 48513.6 -0.98%
Nifty Small 100: 16182.8 -0.64%
Nifty IT: 33137.45 -1.08%
Nifty PSU Bank: 6867.4 -1.24%

News:

Indo Count acquires Wamsutta b...
Volumes spurt at Birlasoft Ltd...
ITC arm inks pact to acquire 1...
ICICI Securities Q4 PAT double...
Mahindra Lifespace records sal...

Hikal Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

19 Apr 2024 | 12:14 PM

301.55

-1.45 (-0.48%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

3.61%

Return (1Y)

Underperformed Nifty 50 by 20.94%
More Volatile

1.67%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.05%
Inconsistent Performer

3/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

329

250

News & Announcements

Board of Hikal recommends Interim Dividend
70 days ago

Board of Hikal recommends Interim Dividend

09 - Feb - 2024 12:00 AM | 70 days ago

Hikal announced that the Board of Directors of the Company at its meeting held on 08 February 2024, has recommended a Interim dividend of Rs.0.60 per share (i.e.30%), subject to the approval of the shareholders.
Powered by Capital Market - Live News
Hikal consolidated net profit declines 38.89% in the December 2023 quarter
70 days ago

Hikal consolidated net profit declines 38.89% in the December 2023 quarter

09 - Feb - 2024 12:00 AM | 70 days ago

Net profit of Hikal declined 38.89% to Rs 16.14 crore in the quarter ended December 2023 as against Rs 26.41 crore during the previous quarter ended December 2022. Sales declined 18.56% to Rs 438.54 crore in the quarter ended December 2023 as against Rs 538.45 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 438.54 538.45 -19
OPM % 14.77 13.85 -
PBDT 50.58 64.06 -21
PBT 21.61 35.79 -40
NP 16.14 26.41 -39
Powered by Capital Market - Live News
Hikal announces board meeting date
76 days ago

Hikal announces board meeting date

02 - Feb - 2024 12:00 AM | 76 days ago

Hikal will hold a meeting of the Board of Directors of the Company on 8 February 2024.
Powered by Capital Market - Live News
Board of Hikal
168 days ago

Board of Hikal

02 - Nov - 2023 12:00 AM | 168 days ago

The Board of Hikal at its meeting held on 02 November 2023 has approved the acquisition of 26% stake in FPEL Ujwal (engaged in wind and solar power) to meet requirements of captive consumer.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Hikal Ltd has increased by 6.83% since past 3 Months
MF shareholding in Hikal Ltd has increased by 11.68% since past 3 Months
FII shareholding in Hikal Ltd has increased by 43.59% since past 1 Year
MF shareholding in Hikal Ltd has increased by 69.06% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	438.54	538.45	-19
OPM %	14.77	13.85	-
PBDT	50.58	64.06	-21
PBT	21.61	35.79	-40
NP	16.14	26.41	-39

General Notifications

My Notifications

Research Notifications

Hikal Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

301.55 -1.45 (-0.48%)

News & Announcements

Price vs Volume

Stock Trivia

Hikal Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

301.55

-1.45 (-0.48%)